Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations

Clinical trial NCT05293626 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05293626
Sponsor: Neurophth Therapeutics Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leber Hereditary Optic Neuropathy (LHON)

Start date: 2023-05-22
Primary completion: 2025-07-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.